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1. Introduction 
Paraquat (PQ, methyl viologen), 1,1'-dimethyl-4,4'-bipyridinium (Figure 1), is a commonly 
used, potent herbicide. It was first synthesised in 1882 by Weidel and Russo, as recorded by 
Hadley in his review of 1979 (Haley, 1979), and its redox properties were discovered by 
Michaelis and Hill in 1933 (Haley, 1979). Initially, PQ was used as an indicator of oxidation-
reduction because in the absence of molecular oxygen, donating an electron to paraquat 
(PQ2+) generated a monocationically stable violet or blue form that is commonly known as 
methyl viologen (Dinis-Oliveira et al., 2008). However, its properties as an herbicide were 
not discovered until 1955, and in 1962, it was introduced into global markets. 
The PQ is registered and used in approximately 100 countries worldwide and is the second 
most commonly used herbicide in the world after gliphosate. Despite this, its use is 
currently banned in the European Union (EU), but the import of products from outside the 
EU for patients who have been treated with PQ has not. 
In its recommended rating of "pesticides by risk," WHO (World Health Organization) 
considers composite PQ to be moderately toxic (Category II) (World Health Organization 
2004). The ECB (European Chemicals Bureau) classifies PQ as being very toxic (R26) by 
inhalation, toxic (R25) orally and moderately toxic (R24) dermally.  
PQ is included in the family of herbicides called bipyridines. It is an herbicide that is non-
selective and functions systemically through contact without acting on the leaves of green 
plants. Among its advantages, it is rapidly absorbed by the leaves of plants that have been 
sprayed, but clay soil causes it to be biologically inactive.  
Its action on plants has been shown to occur on chloroplasts and is based on its redox cycle. 
PQ interferes with photosynthesis at the level of photosystem I. At this point, PQ blocks the 
flow of electrons from ferredoxin and NADP+ so that electrons from photosystem I would 
reduce PQ, which transfers divalent cations (normal state) to monovalent cations (reduced 
state). The monovalent cation reduces oxygen to the superoxide radical (O2-), which is 
produced by the loss of activity of the chloroplasts and the subsequent cell damage that 
leads to plant death. There is controversy about the use of PQ in agriculture because 
herbicides are toxic to humans and the environment, especially when not taking the proper 
precautions. Specifically, in addition to the adverse effects on humans, one of the greatest 
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risks occurs in the absorption of the herbicide when being applied to crops. When rats 
ingested toxic amounts of PQ (either accidentally or voluntary), the initial absorption 
occurred in the small intestine where the amount absorbed by the stomach was negligible, 
especially if there was parallel food intake, and the majority was excreted in the urine and 
feces (Daniel & Gage, 1966). It can also be absorbed and causes damage when it contacts 
with the skin, especially when there was a previously damaged area that would cause an 
abrasion contact zone (J. G. Smith, 1988). When applied with a nasal spray, droplets can 
penetrate the lungs through inhalation. When used in the absence of any physical barrier 
protection (goggles, masks, gloves, etc.), PQ can be highly toxic. Once absorbed into the 
body, PQ could affect different organs, with the liver and kidneys being more sensitive to 
oral ingestion and the lungs being more sensitive to inhalation. In autopsies of dead patients 
that suffered from voluntary PQ poisoning, different organs were damaged. The brain 
damage consisted of widespread edema, subepidermal and subarachnoid haemorrhage 
(which had an uneven distribution in different patients) and inflammation of the meninges, 
which could be a secondary consequence that resulted from lung damage and hypoxia 
based on its characteristics (Grant et al., 1980). 
 
 
Fig. 1. Chemical structure of paraquat 
Together with the correlations observed in epidemiological studies between the use of PQ 
and the development of Parkinson's disease (PD) (Tanner et al., 2011), the structural 
similarity between PQ and the active metabolite (MPP+) of the neurotoxin called MPTP, 
widely accepted as a model of parkinsonism, led us to postulate the existence of a 
relationship between the pesticide and the origin of the disease (Costello et al., 2009; Di 
Monte et al., 1986; Hertzman et al., 1990; Liou et al., 1997). Both neurotoxic effects that 
generated oxidative stress activated different pathways (Richardson et al., 2005). Currently, 
PQ is a valid model for studying neurotoxicity based on oxidative stress, such as for MPP+. 
Further, studies have examined the relationship between the application and exposure of 
this pesticide and the development of PD, which is widely accepted for MPP+, and 
increasing studies have found a role of PQ in oxidative stress and cell death. The toxicity 
induced by PQ as an herbicide makes it toxic to mammalian cells. The redox cycling of PQ 
(Figure 2) in biological systems has two important implications: one is the generation of 
reactive oxygen species (ROS), and the other is the depletion of reducing agents (NADH and 
NADPH) necessary for proper function, affecting different cellular processes, such as the 
synthesis of fatty acids. Similar to inside the plant cell, PQ requires an electron donor to be 
reduced in neurons. The potential standard reduction (E) of a compound indicates the 
affinity of the compound to accept electrons. PQ has an E of -0.45 V. The potential E of the  
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redox couples, NAD+/ NADH and NADP+/ NADPH, is -0.32V and -0.324V, respectively, 
where PQ, under physiological conditions and with the aid of diaphorase within the cell, 
could accept electrons from either reducing agent. The MPP+ E is - 1.18 V, and this indicates 
that PQ has a greater ability to accept electrons than MPP+ (Drechsel & Patel, 2008). Among 
the cellular enzymes that could donate electrons to PQ (PQ-enzymes with diaphorase), it 
has been examined mitochondrial complex I (NADH-ubiquinone reductase complex) 
(Fukushima et al., 1993), thioredoxin reductase (Gray et al., 2007), NADPH, ferredoxin 
oxidoreductase (Liochev et al., 1994), NADPH oxidase (Bonneh-Barkay et al., 2005) and NOS 
(nitric oxide synthase) (Patel et al., 1996) in addition to other enzymes. The mitochondria 
have been shown to be a major source of ROS generation within the PQ-induced 
mechanism, which may induce PQ-diaphorase activity during breathing (Drechsel & Patel, 
2008). Once PQ has been reduced, it could be oxidised by oxygen and generate superoxide 
molecules, which occurs in the cell during oxidative stress. This could be activated by 
different pathways to initiate cell damage through different components and the activation 
of different cellular mechanisms, such as autophagy (R. A. Gonzalez-Polo et al., 2007b), 
dysfunction of the proteasome (Yang & Tiffany-Castiglioni, 2007) and cell death by 
apoptosis (Dinis-Oliveira et al., 2008; R. A. Gonzalez-Polo et al., 2007a; R. A. Gonzalez-Polo et 
al., 2004; McCarthy et al., 2004; Niso-Santano et al., 2011; Niso-Santano et al., 2010; Richardson et 
al., 2005). It is commonly accepted that the key mechanism in PQ-mediated toxicity was due to 
the oxidative stress-derived superoxide anion produced in the redox cycle (Drechsel & Patel, 
2008; Patel et al., 1996). The fact that the key element in PQ-mediated toxicity was the 
generation of superoxide anions was demonstrated by the overexpression or silencing of 
superoxide dismutase (SOD), which led to an alteration of the toxic effects generated by PQ 
(Patel et al., 1996). The superoxide anion generated in the redox cycling of PQ could be 
transformed by various reactions and ROS (Bus & Gibson, 1984) primarily generated by the 
hydroxyl radical (HO-) and hydrogen peroxide (H2O2). These reactive oxygen species have 
been shown to be responsible for the oxidative stress that initiates different cascades inside the 
cell and causes apoptosis. Moreover, both cell death and changes in its regulation have been 
implicated in various diseases, including cancer and neurodegenerative diseases (Leist & 
Jaattela, 2001). More specifically, various studies have linked apoptosis induced following the 
exposure to various toxic compounds with the loss of neurons that occur during the 
development of various neurodegenerative diseases, such as Alzheimer’s disease (AD) (Loo et 
al., 1993) and PD (Andersen, 2001; Fall & Bennett, 1999; Hartmann et al., 2000). In addition, 
previous studies have shown that PQ induced apoptosis in the primary cultures of rat 
cerebellar granule cells (R. A. Gonzalez-Polo et al., 2004) and an increase in the expression of 
genes related to apoptosis in SH-SY5Y cells (Moran et al., 2008). Therefore, we examined PQ as 
a model for studying the neurotoxicity based on the generation of oxidative stress, such as in 
PD, to determine the fundamental role of superoxide anions in the redox cycling of the 
herbicide.  
2. Paraquat induces apoptosis 
The first time that the term apoptosis appeared was in a paper from John Kerr, Andrew 
Wyllie and Alastair Currie, in 1972 (Kerr et al., 1972). The name was derived from the 
‘dropping off’ or ‘falling off’ of petals from flowers or leaves from trees. 
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Apoptosis, or programmed cell death, is characterised by several morphological features, 
such as DNA degradation into oligonucleosomal fragments, chromatin condensation, 
reduction in nuclear and cellular fractions, phosphatidylserine exposure on the outward-
facing side of the plasma membrane and preservation of organelle structure and plasma 
membrane integrity, which leads to the generation of apoptotic bodies, or vesicles in the 
cytoplasm containing tightly packed organelles with or without nuclear fragments. This 
type of cell death contrasts with necrosis, which is uncontrolled, accidental and pathological 
cell death. However, these two cell death pathways have been shown to crosstalk, which has 
been described as the “apoptosis-necrosis continuum” (Zeiss, 2003). 
 
 
Fig. 2. Redox cycle of paraquat  
Previous studies demonstrating the regulation of apoptosis came from Caenorhabditis elegans 
where 131 of the 1090 somatic cells in C. elegans were under the control of programmed cell 
death. In 1985, the Horvitz’s lab discovered four important genes (Ced-3, Ced-4, Ced-9, Egl-1) 
that are involved in the regulation of cell death (Fixsen et al., 1985). Previous studies have 
shown that apoptosis was necessary to define whether cells should live or die. However, 
there are other forms of programmed cell death and other possible mechanisms that have 
not yet been discovered (Debnath et al., 2005; Formigli et al., 2000; Sperandio et al., 2000). 
Several mechanisms of cell death have already been shown to be involved in maintaining 
the balance between life and death (Boya et al., 2005; Lum et al., 2005; Ravikumar et al., 2006). 
Apoptosis most commonly occurs during development and aging as a homeostatic 
mechanism. Although it has been shown to be used as a defence mechanism, such as when 
cells become damaged, during an immune response (Norbury & Hickson, 2001), or as a 
pathological process in cancer and autoimmune lymphoproliferative syndrome in which 
apoptosis was suppressed and led to the development and progression of tumours (Kerr et 
al., 1994; Worth et al., 2006), neurodegenerative diseases, autoimmune diseases and 
ischaemia-associated injury where there is excessive apoptosis (Ethell & Buhler, 2003; 
Freude et al., 2000; C. J. Li et al., 1995). Traditionally, apoptosis has been considered to be an 
irreversible process; however, several reports have demonstrated that these apoptotic cells 
could be rescued from programmed cell death (Geske et al., 2001; Hoeppner et al., 2001; 
Reddien et al., 2001). 
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The mechanisms of apoptosis are highly complex and involve an energy-dependent cascade 
of molecular events. Apoptosis can be initiated by a variety of stimuli, but previous studies 
have shown that there are two main apoptotic pathways: the death receptor or extrinsic 
pathway and the mitochondrial or intrinsic pathway. However, these two pathways are 
connected, and some molecules of one pathway have been shown to influence the other 
pathway (Igney & Krammer, 2002). Further, a third pathway was found in T cells and had 
been shown to occur through cytotoxicity and perforin-granzyme-dependent cell death (via 
granzyme A or granzyme B). Basically, the extrinsic pathway is activated by the death 
receptors (DR), which are localised on the cell surface, through the recognition of their 
specific ligands. In comparison, the intrinsic pathway is initiated after several intracellular 
triggers, called “stress signals”, such as cytoskeleton disruption, hypoxia, DNA damage, 
macromolecular synthesis inhibition and endoplasmic reticulum stress, which induce the 
mitochondria to release pro-apoptotic factors into the cytosol. However, both pathways and 
the granzyme B pathway terminate in the execution pathway that activates caspases 
(cysteine-aspartic acid proteases), and they have been shown to be responsible for 
developing the well-known features of apoptosis (Amarante-Mendes & Green, 1999). In 
contrast, the granzyme A pathway is a caspase-independent cell death pathway, which has 
been shown to act in parallel (Martinvalet et al., 2005). The cell’s decision has been shown to 
be determined by the Bcl-2 protein family. The regulation of the Bcl-2 family of proteins is 
important (Gross et al., 1999). 
It is well known that the toxicity of PQ was due to the production of ROS (Bus & Gibson, 
1984; Mollace et al., 2003), which has been partially generated by xanthine oxidase (Kitazawa 
et al., 1991; Sakai et al., 1995). Therefore, it has been shown that PQ could induce apoptotic 
cell death in cerebellar granule cells using this xanthine oxidase system (R. A. Gonzalez-Polo 
et al., 2004). In addition, it has been reported that PQ induced apoptosis in other animal 
models, such as human lung epithelial cells (Cappelletti et al., 1998), PC12 cells (X. Li & Sun, 
1999), mouse 32D cells (Fabisiak et al., 1997), primary mesencephalic cells and dopaminergic 
neuronal cells (Gomez-Sanchez et al., 2010; Peng et al., 2004).  
PQ has structural homology to MPP+, which has been linked to PD in epidemiological studies 
(Hertzman et al., 1990; Liou et al., 1997). In this vein, PINK1-silenced neuroblastoma cells were 
more sensitive and exhibited increased apoptosis compared with control cells following PQ 
treatment (Gegg et al., 2009). Silencing DJ-1 in neuroblastoma cells induced apoptotic cell 
death, and the treatment with PQ increased apoptosis (R. Gonzalez-Polo et al., 2009). 
The cytotoxic actions of PQ have been shown to involve oxidative stress by producing 
superoxide anions through the mitochondrial electron transport chain (Dinis-Oliveira et al., 
2006; McCormack et al., 2002). PQ has been shown to be reduced by mitochondrial complex I 
and, thus, impair the respiration complex that led to the generation of ROS to induce 
selective neurodegeneration in dopaminergic neurons in the substantia nigra pars compacta 
(Fei et al., 2008) and apoptosis by activating different intracellular pathways. PQ has been 
shown to induce apoptosis through the mitochondrial intrinsic pathway associated with p53 
(Yang & Tiffany-Castiglioni, 2008). JNK proteins have been implicated in dopaminergic 
neuronal death induced by rotenone, PQ and 6-hydroxydopamine (6-OHDA) (Choi et al., 
1999; Klintworth et al., 2007; Newhouse et al., 2004; Niso-Santano et al., 2006). PQ activates 
cell death through JNK and its downstream target c-Jun (Peng et al. 2004) and induces high 
levels of pro-apoptotic Bcl-2 family members (Bak, Bid, BNip3 and Noxa) in conjunction 
with cytochrome c release and caspase-3 activation (Fei et al., 2008). 
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Another mechanism by which PQ has been shown to activate cell death involves chronic 
endoplasmic reticulum (ER) stress (Chinta et al., 2008; Holtz & O'Malley, 2003; Ryu et al., 
2002). The increase in the expression of GRP family proteins, the increased phosphorylation 
of eIF2a and the induction of GADD153 expression was reported following PQ treatment in 
dopaminergic N27 cells (Chinta et al., 2008) . These results were consistent with previous 
studies that demonstrated the transcriptional upregulation of ER stress and unfolded 
protein response (UPR)-specific proapoptotic genes following exposure to MPP+ and 6-
OHDA (Holtz & O'Malley, 2003; Ryu et al., 2002). Several neurodegenerative diseases 
feature the accumulation of abnormal proteins as a result of the inhibition of the cellular 
proteasome activity and ER stress. Paraquat treatment led to a significant decrease in 20S 
proteasome activity (Chinta et al., 2008). The inhibition of proteasome activity initiated the 
formation and accumulation of ubiquitinated protein aggregates (Lam et al., 2002).  
PQ was shown to induce IRE1/ASK1/JNK activation (Niso-Santano et al., 2010; Yang et al., 
2009). IRE1 is an ER-resident transmembrane protein that is activated in response to ER 
stress. IRE1 phosphorylates ASK1, which has been shown to play a key role in the activation 
of p38/JNK signalling in neurotoxin-induced cell culture models of PD, such as MPTP and 
paraquat-induced apoptosis in dopaminergic neuronal cells (Niso-Santano et al., 2010).  
Recent studies have shown that paraquat induced acetylation of core histones in cell culture 
models of PD and that the inhibition of HAT activity by anacardic acid significantly 
attenuated paraquat-induced caspase-3 enzyme activity, indicating that histone acetylation 
played a role in paraquat-induced apoptosis (Song et al.). 
3. PQ induces autophagy 
Autophagy is an intracellular lysosome-mediated catabolic mechanism that is responsible 
for the bulk degradation and recycling of damaged or dysfunctional cytoplasmic 
components and intracellular organelles (Klionsky & Emr, 2000). Autophagy is an 
evolutionarily conserved cellular response to both extracellular stress conditions (nutrient 
deprivation and hypoxia) and intracellular stress conditions (accumulation of damaged 
organelles and cytoplasmic components). Autophagy is a physiological degradative process 
employed during embryonic growth and development, cellular remodelling and the 
biogenesis of some subcellular organelles, such as multi-lamellar bodies (Filonova et al., 
2000; Hariri et al., 2000; Sattler & Mayer, 2000). Autophagic cell death has been shown to 
involve the accumulation of autophagic vacuoles in the cytoplasm of dying cells and in 
mitochondrial dilation and the enlargement of the ER and the Golgi apparatus. 
Different types of autophagy are classified depending on the mechanism driving the 
degradation of the substrate in the lysosomal lumen (Klionsky et al., 2007). We could 
distinguish three types of autophagy:  
1. Macroautophagy: is often referred to as “autophagy”. In this process, the material to be 
degraded becomes trapped in double-membrane vesicles to form a structure known as the 
autophagosome (Baba et al., 1994; Fengsrud et al., 1995). Macroautophagy has been shown to 
involve a number of genes called ATGs (autophagy-related genes), which have been shown 
to encode more than 30 proteins. Autophagosome membranes are derived from a structure 
called the pre-autophagosome, phagophore or early autophagosome (Fengsrud et al., 1995; 
Mizushima et al., 2001; Suzuki et al., 2001). The first step towards the formation of the late 
autophagosome is the expansion of the phagophore (pre-autophagosome) membrane. 
Therefore, the carbon terminus of the protein LC3 (encoded by the gene ATG8) is attached to 
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a residue of phosphatidyl-ethanolamine (PE) in the membrane of the phagophore and with 
two other proteins encoded by ATG12 and ATG5 that also bind to the inner membrane, 
leading to the formation of the autophagosome. This autophagosome then fuses with 
lysosomes, forming the autophagolysosome where the degradation of the material occurs 
due to the action of lysosomal enzymes.  
2. Microautophagy: In this process, the material to be degraded becomes trapped by the 
lysosomes through the invagination of its membrane. Once introduced into the lysosome, 
the material becomes degraded by lysosomal enzymes similar to macroautophagy.  
3. Chaperone-mediated autophagy (CMA): In this autophagy, the material to be degraded 
is damaged or misfolded protein that has been translocated into the lysosomal lumen 
through the lysosomal membrane. This translocation is mediated by cytosolic and lysosomal 
chaperones, involving the carrier LAMP-2A (lysosome-associated membrane protein 2A). 
Dysfunctions in autophagy have been implicated in various diseases, such as cancer (Kondo 
& Kondo, 2006), cardiomyopathy (Nakai et al., 2007) or neurodegenerative processes 
(Martinez-Vicente & Cuervo, 2007; Ravikumar & Rubinsztein, 2004). In neurodegenerative 
diseases, an increase in the formation of autophagic vacuoles in the substantia nigra of 
patients with PD (Anglade et al., 1997), Huntington's disease (Kegel et al., 2000; Sapp et al., 
1997) and AD (Butler & Bahr, 2006; Nixon et al., 2005; Zheng et al., 2006) has been shown. 
This raises questions about the role of autophagy in these neurodegenerative processes. 
Previous studies have suggested that the increased number of autophagic vacuoles was 
responsible for neuronal death; however, in contrast, other studies have suggested a 
protective role for autophagy, contributing to the increased degradation of damaged 
proteins, which could induce apoptosis (U. Bandyopadhyay & Cuervo, 2007). 
Changes have been described in the ubiquitin-proteasome system associated with PD. 
Several studies have suggested that once the ubiquitin-proteasome system has been 
damaged, autophagy becomes over-regulated, increasing the number of protein aggregates 
degraded by this mechanism (Iwata et al., 2005; Massey et al., 2006), which has been 
considered to be the default pathway when protein aggregates could not be eliminated by 
the proteasome (Olanow, 2007; Rideout et al., 2004). However, if the pathogenic insult was 
maintained, this compensatory mechanism was unable to maintain cellular balance, leading 
to neuronal death (Trojanowski & Lee, 2000). 
Recently, converging evidence suggests that the impairment of homeostatic mechanisms 
processing unwanted and misfolded proteins plays a central role in the pathogenesis in PD 
(Olanow, 2007). Impairment of the autophagy-lysosomal pathway has been shown to be 
related to the development of PD (Pan et al., 2008). Activation of autophagy was also 
identified within peripheral blood mononuclear cells from PD patients (Prigione et al., 2010). 
This self-regulatory concept of autophagy supports the hypothesis that increased signalling 
of autophagy occurred in mice with a malfunctioning lysosome that was accompanied by 
the aggregation of the protein α-synuclein (Meredith et al., 2002). Increased levels of α-
synuclein were reported in both the frontal cortex and the ventral midbrain, and α-synuclein 
positive inclusions in the substantia nigra neurons of mice treated with PQ were found 
(Manning-Bog et al., 2002). The association of dopaminergic neuronal death with α-
synuclein upregulation and aggregation following PQ toxicity is relevant as a PD model. 
Because PQ induced the accumulation of autophagic vacuoles and increased the 
degradation of proteins in the cytoplasm of SH-SY5Y cells (R. A. Gonzalez-Polo et al., 2007a), 
this indicates that the increased oxidative stress could activate autophagy in the initial 
stages of mitochondrial dysfunction to have a protective role in paraquat-induced cell death 
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(R. A. Gonzalez-Polo et al., 2007a, 2007b). Moreover, our group has shown that PQ exposure 
induced an early reticulum stress response that was correlated with the adaptive activation 
of autophagy, characterised by the accumulation of autophagic vacuoles, activation of 
beclin-1, accumulation of LC3-II, p62 degradation, and mammalian target of rapamycin 
dephosphorylation (R. A. Gonzalez-Polo et al., 2007a, 2007b; Niso-Santano et al., 2011). This 
response was increased in cells that overexpressed wild-type (WT) ASK1 (apoptosis signal 
kinase 1) protein. In this model, the inhibition of autophagy caused an exacerbation of the 
apoptosis induced by ASK1 WT overexpression with or without PQ. These results suggest 
that autophagy has an important role in the cell death/survival events produced by PQ and 
ASK1 that contribute to neuronal degeneration.  
Therefore, increased autophagy might be a new strategy for the treatment of 
neurodegenerative diseases (Menzies et al., 2006). It is encouraging to consider enhancing 
the autophagic capacity as a therapeutic strategy in the prevention of neurodegeneration 
because studies have shown that the abnormal regulation of autophagic pathways may lead 
to apoptosis and cell death (Walls et al., 2010). 
 
 
Fig. 3. Schematic representation of the different types of autophagy 
4. Paraquat and Parkinson´s disease-related proteins 
As previously described, PD is characterised by the selective degeneration of dopaminergic 
neurons. The aetiology of PD is unknown but has a multifactorial origin that involves both 
genetic and environmental factors. The interaction of both factors was, in part, involved in 
the selective death of dopaminergic neurons observed in PD. Apart from the studies that 
have identified human mutations as a basis for disease, the high number of individuals with 
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sporadic PD have an unknown aetiology. These individuals have multifactorial disease in 
which the environment plays important roles. PQ is an environmental agent that has been 
associated with PD. A recent study by Caroline Tanner concluded that people using PQ and 
rotenone were 2.5 times more likely to develop PD than those who were not in contact with 
them (Tanner et al., 2011). Therefore, there is a relationship between the toxicity of PQ and 
PD. This interaction is not known; however, several studies directly indicate the interaction 
of PQ with PARK genes. 
The development of PD was attributed to different events, such as mitochondrial 
dysfunction, oxidative stress or the aggregation of proteins. These events could be important 
to understanding the relationship between PQ and PARK genes (Table 1). 
 
 
Gene 
 
Locus 
 
Protein name
 
Inheritance 
 
Function 
 
 
PARK 1/4 
 
4q21.3-q22 

-synuclein 
 
AD 
 
Lewy`s body component 
PARK 2 6q25-27 Parkin AR E3 ubiquitin ligase 
PARK 3 2p13 ¿? AD ¿? 
PARK 5 4p14 UCHL-1 AD 
Ubiquitin C-terminal 
hydrolase 
PARK 6 1p35-36 PINK1 AR Mitochondrial kinase 
PARK 7 1p36 DJ-1 AR Antioxidant agent 
PARK 8 12q12 LRRK2 AD Kinase, GTPase 
PARK 9 1p36 ATP13A2 AR ATPase,  cationic transport 
PARK 10 1p32 ¿? AD ¿? 
PARK 11 2q36-q37 GIGYF2 AD 
Receptor tyrosine kinase 
signaling 
PARK 12 Xq21-q25 ¿? X-linked ¿? 
PARK 13 2p13 HTRA2/OMI AD Serine protease 
PARK 14 22q13.1 PLA2G6 AR Fosfolipase A2 
PARK 15 22q11.2 FBXO7 AR E3 ubiquitin ligase 
PARK 16 1q32 RAB7L1 ¿? ¿? 
PARK 17 4p GAK/DGKQ ¿? ¿? 
PARK 18 
 
6p 
 
HLA-DRA 
 
¿? 
 
¿? 
 
Table 1. Some characteristics of PARK genes 
The increase in oxidative stress has been observed in the substantia nigra of PD brains, as 
demonstrated by the increased lipid, protein, and DNA oxidation or increased total iron 
content (Bagchi et al., 1995; Mattson, 2006). This alteration of cellular redox balance may be 
produced by different mechanisms because of the enzymatic conversion to secondary 
reactive products and/or ROS by the depletion of antioxidant defences or the impairment of 
antioxidant enzyme function (Abdollahi et al., 2004). Autosomal recessive PD-associated 
genes such as parkin, DJ-1 and PTEN-induced putative kinase 1 (PINK), have been shown to 
be involved in mitochondrial function, which suggests that mitochondrial dysfunction and 
the generation of ROS were central events in the pathogenesis of PD. Therefore, further 
study of the implication of these proteins in PQ toxicity would be of interest.  
www.intechopen.com
 
Toxicity and Drug Testing 
 
246 
In contrast, the misfolding and aggregation of proteins is another pathway of cell toxicity in 
PD. The failure of α-synuclein (PD-related protein) clearance by the ubiquitin-proteasome 
system UPS (ubiquitin proteosome system) led to its accumulation over time and to the 
formation of fibrillar aggregates and Lewy bodies. In this vein, there is a relationship 
between PQ toxicity and PD because exposure to PQ has been shown to induce proteasome 
dysfunction and α-synuclein aggregation (Ding & Keller, 2001; Fei et al., 2008; Goers et al., 
2003; Manning-Bog et al., 2002; Yang & Tiffany-Castiglioni, 2007).  
Therefore, there is a relationship between the toxicity exerted by PQ and different PARK 
genes. 
4.1 α-synuclein (PARK1, PARK4) and paraquat 
Lewy bodies (LBs) are abnormal aggregates of protein that develop inside the nerve cells in 
PD. The presence of α-synuclein in these aggregates has been shown to play an important 
role in the formation of LBs (Masliah et al., 2000; Spillantini et al., 1997). The mechanisms 
that promote intraneuronal α-synuclein assembly remain poorly understood. Missense 
mutations (A53T, A30P and E46K) or multiplications (duplications and triplications) in the 
α-synuclein gene (PARK1/4) caused autosomal-dominant parkinsonism (Polymeropoulos et 
al., 1997), but it is still unclear whether fibrils of aggregated α-synuclein, as found in LBs, 
have a causative role in the more common forms of PD or could be a marker for the 
underlying pathogenetic process. α-synuclein has three common forms, monomers, dimers, 
and protofibrils, and it is thought that an excess of the protofibril forms inhibited UPS in 
vitro (McNaught et al., 2001) and in vivo (Dyllick-Brenzinger et al., 2010). α-synuclein 
protofibrils have been shown to directly lead to oxidative stress that could further impair 
UPS by reducing ATP levels, inhibiting the proteasome and by the oxidation of parkin.  
Studies have indicated that the interaction of environmental factors with alterations in α-
synuclein might be involved in the aetiology of PD. The interaction of α-synuclein with PQ 
toxicity has been extensively examined. PQ has been shown to potentiate α-synuclein-
induced toxicity (Norris et al., 2007). PQ preferentially binds to the partially folded α-
synuclein intermediate because PQ has been shown to induce a conformational change in α-
synuclein and significantly increase the rate of the formation of α-synuclein fibrils in vitro 
(Uversky et al., 2001). In vivo, rodent studies have shown that the administration of PQ 
induced an increase in α-synuclein levels in the brain. These results suggest that the 
upregulation of α-synuclein as a result of toxic insult and the direct interactions between the 
protein and environmental agents are potential mechanisms leading to α-synuclein 
pathology in neurodegenerative disorders (Manning-Bog et al., 2002). 
4.2 PINK1/PARKIN (PARK6/PARK2) and paraquat 
Another hallmark PD characteristic is mitochondrial dysfunction. In post-mortem analysis in 
the substantia nigra, some patients with PD showed complex I deficiency (Schapira et al., 
1989). In addition, the oxidative stress was higher in patients with parkinsonism (Jenner, 
2003). In this sense, PINK1 (PARK6) and Parkin (PARK2) are 2 genes related to PD that may 
be involved in the regulation of mitochondrial homeostasis. 
Parkin mutations were first linked to an autosomal recessive juvenile-onset form of PD in 
Japanese families (Kitada et al., 1998; Matsumine et al., 1997). Numerous parkin mutations 
have been described, including deletions, multiplications and missense mutations (Hattori 
& Mizuno, 2004). Parkin protein acts as an E3 ubiquitin protein ligase in the UPS (Shimura et 
al., 2000). Ubiquitination of proteins is essential to start to proteasomal protein degradation. 
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Therefore, parkin mutations should lead to an incorrect ubiquitination, blocking the 
degradation of the protein and leading to protein accumulation. Mutant parkin has been 
shown to impair mitochondrial function and morphology in human fibroblasts and to 
sensitise the cells to an insult with PQ, producing higher levels of oxidised proteins in the 
Parkin-mutant samples than in controls (Grunewald et al., 2010). PQ has also been 
demonstrated to induce alterations in parkin solubility and result in its intracellular 
aggregation (C. Wang et al., 2005). 
PINK1  is a serine/threonine kinase capable of autophosphorylation. This protein has an N-
terminal mitochondrial targeting signal (MTS), is synthesised as a full-length version (FL) 
and is processed into at least two cleaved forms (∆1 and ∆2) (W. Lin & Kang, 2008). PINK1 is 
considered to be a mitochondrial protein with a role in protecting against oxidative stress 
and apoptosis in in vitro models (Valente et al., 2004). Mutations in PINK1 have been 
associated with autosomal recessive PD (Valente et al., 2004) and with PINK1 KO flies with 
motor deficits and disorganised mitochondrial morphology (Clark et al., 2006). For the link 
between PINK1 and the toxicity of PQ, studies using silencer PINK1 have shown an increase 
in oxidative stress and ATP depletion and a higher sensitivity to PQ (Gegg et al., 2009). 
Similar results have been observed in studies that examined PINK1 nonsense and missense 
mutations (Grunewald et al., 2009).  
4.3 DJ-1 (PARK7) and paraquat 
DJ-1 is a small protein that belongs to the ThiJ/PfpI protein superfamily (S. Bandyopadhyay 
& Cookson, 2004) that was initially identified as an oncogene that interacted with H-Ras 
(Nagakubo et al., 1997). The involvement of DJ-1 in neurodegeneration was found when it 
was discovered that the DJ-1 gene (PARK7) was the cause of autosomal recessive PD in a 
Dutch family (Bonifati et al., 2003). Different pathogenic mutations have been identified in 
the PARK7 gene, including truncation, exonic deletions and homozygous and heterozygous 
missense mutations (Hague et al., 2003). L166P is the most dramatic point mutation, whereas 
other mutations, such as A104T and M26I, have a weaker destabilising effect on the protein 
structure. The L166P mutation is located in the centre of α-helix 7, which is a major part of 
the hydrophobic patch. This mutation has been shown to destabilise the dimeric structure of 
DJ-1 by promoting the unfolding of its C-terminal region, resulting in rapid degradation 
(Miller et al., 2003; Moore et al., 2003). However, the frequency of DJ-1 mutations was low, 
with it being estimated at approximately 1-2 % in early onset PD. The physiological function 
of DJ-1 is unclear, but it may have a role in protecting against mitochondrial damage in 
response to oxidative stress (Canet-Aviles et al., 2004).  
The link between DJ-1 and PQ exposure has been correlated with autophagy and the 
apoptotic process. An active role for DJ-1 in the autophagic response produced by PQ has 
been suggested. In a study using transfected cells exposed to PQ and DJ-1-specific siRNA, 
an inhibition of the autophagic events induced by the herbicide, the increased sensitisation 
during PQ-induced apoptotic cell death and the exacerbation of apoptosis in the presence of 
the autophagy inhibitor 3-methyladenine (R. A. Gonzalez-Polo  et al., 2009) had been shown. 
Interestingly, PQ-induced toxicity and proteasome dysfunction was potentiated in a DJ-1 
deficiency (Lavara-Culebras & Paricio, 2007; Menzies et al., 2005). In another study using DJ-
1 null cells from the DJ-1(-/-) mouse embryos, DJ-1 null cells showed a resistance to PQ-
induced apoptosis, including reduced poly (ADP-ribose) polymerase and procaspase-3. 
Therefore, DJ-1 could be important to maintain mitochondrial complex I, and complex I 
could be a key target in the interaction of PQ toxicity and DJ-1 in PD (Kwon et al., 2011). In 
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DJ-1-deficient mice treated with PQ, decreased proteasome activities and increased 
ubiquitinated protein levels were found, and these pathologies were not observed in brain 
regions of normal mice treated with PQ (Yang et al., 2007). In another mouse study, the loss 
of DJ-1 increased the sensitivity to oxidative insults but did not produce neurodegeneration. 
Similar results have been found when analysing Drosophila melanogaster mutants for the DJ-1 
orthologous genes, DJ-1alpha and DJ-1beta, that resulted in increased sensitivity to PQ 
insults, reduced lifespan and motor impairments. However, these mutations did not lead to 
dopaminergic neuronal loss (Lavara-Culebras & Paricio, 2007) 
4.4 LRRK2 (PARK8) and paraquat 
In 2002, PARK8 gene mutations were discovered as a major genetic cause associated with 
hereditary parkinsonism (Paisan-Ruiz et al., 2004). The PARK8 gene was associated with PD 
in studies of a Japanese Sagamihara family who responded positively to treatment with L-
DOPA, which had parkinsonism that presented with an unknown aetiology of the disease 
(Funayama et al., 2002). Other studies examined two additional families (German and 
Canadian) who also had an autosomal dominant, late-onset parkinsonism (Zimprich et al., 
2004).  
In the LRRK2 structure, two functional domains, kinase and GTPase domains, were shown 
to be present. The G2019S mutation was present in the kinase domain specific to the binding 
site for Mg2+ (Kachergus et al., 2005). This mutation facilitates the access of the kinase 
domain to its substrates, which increases autophosphorylation 2.5-fold the phosphorylation 
of other substrates, such as myelin basic protein (MBP), 3-fold for the LRRK2 
autophosphorylation without the presence of this mutation (Jaleel et al., 2007; West et al., 
2005), which is responsible for the increased toxicity of this molecule (Greggio et al., 2006). In 
the GTPase domain, the R1441C has been the most studied mutation, and there is 
controversy as to the influence of GTPase mutations on the kinase activity that was 
observed in some studies in which the increase was similar (Guo et al., 2007) or had no 
change (Jaleel et al., 2007).  
LRRK2 has been shown to play different roles in the cell; however, little information is 
available. Based on the data we found from the protein interactions, there was a relationship 
between LRRK2 and cytoskeletal reorganisation (Gandhi et al., 2008), maintenance functions 
and cell morphology (Plowey et al., 2008), protein transport through synaptic vesicles (Shin 
et al., 2008), and the ubiquitination process (Ko et al., 2009). There have also been studies that 
relate LRRK2 and apoptosis (Ho et al., 2009). Previous studies have shown a relationship 
between LRRK2 and other PD-related proteins, such as parkin (Ng et al., 2009; W. W. Smith 
et al., 2005), PINK-1 and DJ-1 (Venderova et al., 2009) or α-synuclein (X. Lin et al., 2009). The 
interaction of LRRK2 with PQ is not clear. Studies in Drosophila melanogaster in which the 
deletion of kinase domain of LRRK2 did not induce a higher sensitivity to the PQ stimulus 
has been shown (D. Wang et al., 2008). In contrast, in Caenorhabditis elegans studies, the 
expression of human LRRK2 protein protected against PQ, which increased nematode 
survival in response to agents that cause mitochondrial dysfunction. However, protection 
by G2019S, R1441C, or kinase-dead LRRK2 was less effective than wild-type LRRK2 (Saha et 
al., 2009). In another study with Caenorhabditits elegans, PINK1 mutant genes have been 
observed in a minor mitochondrial length and increased PQ sensitivity of the nematode. 
Moreover, the mutants also displayed defects in axonal outgrowth of a pair of canal-
associated neurons. We demonstrated that in the absence of lrk-1 (the C. elegans homologue 
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of human LRRK2), all phenotypic aspects of PINK1 loss-of-function mutants were 
suppressed (Samann et al., 2009) 
5. Conclusion  
PQ has been suggested as a potential aetiological factor for the development of PD. We have 
demonstrated that PQ was able to induce cell death by activating apoptotic machinery. 
However, PQ also displayed characteristics of autophagy, a degradative mechanism 
involved in the recycling and turnover of cytoplasmic constituents from eukaryotic cells. 
Finally, the cells suffered apoptotic death when the PQ remained. Whereas caspase 
inhibition retarded cell death, autophagy inhibition increased apoptotic cell death induced 
by PQ. These findings suggest a relationship between autophagy and apoptotic cell death 
following paraquat exposition and allows us to further investigate and increase our 
knowledge regarding the toxicity of paraquat and its relationship with the origin of PD. 
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